1
|
Petit G, Leclercq S, Quoilin C, Poncin M, Starkel P, Maurage P, Rolland B, Dricot L, De Timary P. Links between psychopathological symptoms and cortical thickness in men with severe alcohol use disorder: A Magnetic Resonance Imaging study. Neuropsychopharmacol Rep 2023; 43:513-520. [PMID: 37013368 PMCID: PMC10739149 DOI: 10.1002/npr2.12331] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/07/2022] [Revised: 02/21/2023] [Accepted: 02/27/2023] [Indexed: 04/05/2023] Open
Abstract
BACKGROUND Anxiety and depression are psychopathological states frequently co-occurring with severe alcohol use disorder (SAUD). These symptoms generally disappear with abstinence but may persist in some patients, increasing the relapse risk. METHODS The cerebral cortex thickness of 94 male patients with SAUD was correlated with symptoms of depression and anxiety, both measured at the end (2-3 weeks) of the detoxification treatment. Cortical measures were obtained using surface-based morphometry implemented with Freesurfer. RESULTS Depressive symptoms were associated with reduced cortical thickness in the superior temporal gyrus of the right hemisphere. Anxiety level was correlated with lower cortical thickness in the rostral middle frontal region, inferior temporal region, and supramarginal, postcentral, superior temporal, and transverse temporal regions of the left hemisphere, as well as with a large cluster in the middle temporal region of the right hemisphere. CONCLUSIONS At the end of the detoxification stage, the intensity of depressive and anxiety symptoms is inversely associated with the cortical thickness of regions involved in emotions-related processes, and the persistence of the symptoms could be explained by these brain deficits.
Collapse
Affiliation(s)
- Géraldine Petit
- Psychiatric Emergency Unit, Department of Adult PsychiatryCliniques Universitaires Saint LucBrusselsBelgium
- Institute of Neuroscience, UCLouvainBrusselsBelgium
| | - Sophie Leclercq
- Laboratory of Nutritional PsychiatryInstitute of Neuroscience, UCLouvainBrusselsBelgium
| | | | - Marie Poncin
- Institute of Neuroscience, UCLouvainBrusselsBelgium
- Louvain Experimental Psychopathology Research Group (LEP), Psychological Sciences Research Institute (IPSY)UCLouvainLouvain‐la‐NeuveBelgium
| | - Peter Starkel
- Laboratory of Hepato‐GastroenterologyUCLouvainBrusselsBelgium
- Department of Hepato‐GastroenterologyCliniques Universitaires Saint LucBrusselsBelgium
| | - Pierre Maurage
- Louvain Experimental Psychopathology Research Group (LEP), Psychological Sciences Research Institute (IPSY)UCLouvainLouvain‐la‐NeuveBelgium
| | - Benjamin Rolland
- CH Le Vinatier, Service Universitaire d'Addictologie de Lyon (SUAL)BronFrance
| | | | - Philippe De Timary
- Institute of Neuroscience, UCLouvainBrusselsBelgium
- Laboratory of Hepato‐GastroenterologyUCLouvainBrusselsBelgium
- Department of Adult PsychiatryCliniques Universitaires Saint LucBrusselsBelgium
| |
Collapse
|
2
|
Lange PW, Clayton-Chubb DI, Watson R, Maier AB. Results from a double blinded, randomised, placebo-controlled, feasibility trial of melatonin for the treatment of delirium in older medical inpatients. Intern Med J 2020; 51:33-41. [PMID: 31985112 DOI: 10.1111/imj.14763] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/22/2019] [Revised: 01/08/2020] [Accepted: 01/09/2020] [Indexed: 11/30/2022]
Abstract
BACKGROUND Delirium is common in elderly inpatients, causing distress, cognitive decline and death. No known intervention improves the course of delirium; current treatments are symptomatic, and limited by lack of efficacy and adverse effects. There is an urgent need to find an effective treatment for delirium. AIMS To determine the feasibility of a trial of oral melatonin 5 mg nightly for five nights for the treatment of delirium in older medical inpatients, and determine the participants required to demonstrate a clinically and statistically significant decrease in severity of delirium in older medical inpatients treated with melatonin. METHODS This was a double blinded, randomised controlled trial in general internal medicine units of a tertiary teaching hospital. Older (≥70 years) inpatients with confusion assessment method positive hyperactive or mixed delirium were suitable for inclusion. Subjects received melatonin 5 mg oral nightly for five nights or matching placebo. The primary outcome was the Memorial Delirium Assessment Scale (MDAS) administered daily. RESULTS No adverse effects occurred due to melatonin. In the treatment group, the mean change in MDAS from baseline during treatment period was 2.5 ± 5.0 points, in the placebo group, 2.1 ± 4.1 points, a non-significant difference. A power calculation accounting for drop-out (31.0%), suggests 120 participants would be required to demonstrate with 90% power that melatonin 5 mg reduces the severity of delirium by 3 points or more on MDAS. CONCLUSIONS A trial of the hypothesis that 5 mg melatonin nightly for five nights reduces delirium severity in older medical inpatients would require 120 patients, and is feasible.
Collapse
Affiliation(s)
- Peter W Lange
- Department of Medicine and Aged Care, @AgeMelbourne, The University of Melbourne, The Royal Melbourne Hospital, Melbourne, Victoria, Australia
| | - Daniel I Clayton-Chubb
- Department of Medicine and Aged Care, @AgeMelbourne, The University of Melbourne, The Royal Melbourne Hospital, Melbourne, Victoria, Australia
| | - Rosie Watson
- Department of Medicine and Aged Care, @AgeMelbourne, The University of Melbourne, The Royal Melbourne Hospital, Melbourne, Victoria, Australia
| | - Andrea B Maier
- Department of Medicine and Aged Care, @AgeMelbourne, The University of Melbourne, The Royal Melbourne Hospital, Melbourne, Victoria, Australia.,Department of Human Movement Sciences, @AgeAmsterdam, Faculty of Behavioural and Movement Sciences, Vrije Universiteit Amsterdam, Amsterdam Movement Sciences, Amsterdam, The Netherlands
| |
Collapse
|
3
|
Uhlmann A, Bandelow B, Stein DJ, Bloch S, Engel KR, Havemann-Reinecke U, Wedekind D. Grey matter structural differences in alcohol-dependent individuals with and without comorbid depression/anxiety-an MRI study. Eur Arch Psychiatry Clin Neurosci 2019; 269:285-294. [PMID: 29372325 DOI: 10.1007/s00406-018-0870-x] [Citation(s) in RCA: 13] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/14/2017] [Accepted: 01/15/2018] [Indexed: 10/18/2022]
Abstract
Although depression and anxiety disorders are common comorbid conditions in alcohol dependence, few structural brain imaging studies have compared alcohol-dependent subjects with and without such comorbidity. In the current study, brain scans of 35 alcohol-dependent with and 40 individuals without diagnosis of a comorbid ICD-10 depressive or anxiety disorder receiving detoxification inpatient treatment were evaluated. Thickness and volumes of automatically segmented neuroanatomical structures were measured in FreeSurfer. Furthermore, associations of brain structure with biological markers and clinical severity markers of alcohol dependence were assessed. Despite comparable addiction severity, the non-comorbid group had evidence of higher cytotoxic effects of alcohol use on hepatic and haematological markers, and showed significantly smaller volumes of total cerebral, and cerebellar grey matter. Similarly, they showed unexpected smaller hippocampal and nucleus accumbens volumes, and thinner frontal, temporal and occipital cortices. Smaller brain volumes correlated with increased markers of hepatic and haematological dysfunction, and with longer duration of alcohol dependence in the non-comorbid group. Evidence of higher biomarkers of alcohol use may be indicative of more severe alcohol dependence or higher vulnerability to ethanol toxicity in this group. Furthermore, psychopathology-related drug treatment, which occurred in 53% of the comorbid group over the recent years, or tissue inflammation may have a moderate effect on the grade of cerebral atrophy in alcohol-dependent patients. Longitudinal studies are needed to investigate this issue more fully.
Collapse
Affiliation(s)
- A Uhlmann
- Department of Psychiatry and Mental Health, University of Cape Town, Cape Town, South Africa.,Department of Psychiatry, Stellenbosch University, Cape Town, South Africa
| | - B Bandelow
- Department of Psychiatry and Psychotherapy, University Medical Centre, University of Goettingen, von-Siebold-Strasse 5, 37075, Göttingen, Germany
| | - D J Stein
- Department of Psychiatry and Mental Health, University of Cape Town, Cape Town, South Africa
| | - S Bloch
- Department of Psychiatry and Psychotherapy, University Medical Centre, University of Goettingen, von-Siebold-Strasse 5, 37075, Göttingen, Germany
| | - K R Engel
- Department of Psychiatry and Psychotherapy, University Medical Centre, University of Goettingen, von-Siebold-Strasse 5, 37075, Göttingen, Germany
| | - U Havemann-Reinecke
- Department of Psychiatry and Psychotherapy, University Medical Centre, University of Goettingen, von-Siebold-Strasse 5, 37075, Göttingen, Germany.,Centre of Nanomicroscopy and Molecular Biology of the Brain, CNMPB, Goettingen University Medical Centre, Goettingen, Germany
| | - Dirk Wedekind
- Department of Psychiatry and Psychotherapy, University Medical Centre, University of Goettingen, von-Siebold-Strasse 5, 37075, Göttingen, Germany.
| |
Collapse
|
4
|
Nitchingham A, Kumar V, Shenkin S, Ferguson KJ, Caplan GA. A systematic review of neuroimaging in delirium: predictors, correlates and consequences. Int J Geriatr Psychiatry 2018; 33:1458-1478. [PMID: 28574155 DOI: 10.1002/gps.4724] [Citation(s) in RCA: 41] [Impact Index Per Article: 5.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/02/2016] [Accepted: 03/23/2017] [Indexed: 12/17/2022]
Abstract
OBJECTIVE Neuroimaging advances our understanding of delirium pathophysiology and its consequences. A previous systematic review identified 12 studies (total participants N = 764, delirium cases N = 194; years 1989-2007) and found associations with white matter hyperintensities (WMH) and cerebral atrophy. Our objectives were to perform an updated systematic review of neuroimaging studies in delirium published since January 2006 and summarise the available literature on predictors, correlates or outcomes. METHODS Studies were identified by keyword and MeSH-based electronic searches of EMBASE, MEDLINE and PsycINFO combining terms for neuroimaging, brain structure and delirium. We included neuroimaging studies of delirium in adults using validated delirium assessment methods. RESULTS Thirty-two studies (total N = 3187, delirium N = 1086) met the inclusion criteria. Imaging included magnetic resonance imaging (MRI; N = 9), computed tomography (N = 4), diffusion tensor imaging (N = 3), transcranial Doppler (N = 5), near infrared spectroscopy (N = 5), functional-MRI (N = 2), single photon emission computed tomography (N = 1), proton MRI spectroscopy (N = 1), arterial spin-labelling MRI (N = 1) and 2-13 fluoro-2-deoxyglucose positron emission tomography (N = 1). Despite heterogeneity in study design, delirium was associated with WMH, lower brain volume, atrophy, dysconnectivity, impaired cerebral autoregulation, reduced blood flow and cerebral oxygenation and glucose hypometabolism. There was evidence of long-term brain changes following intensive care unit delirium. CONCLUSIONS Neuroimaging is now used more widely in delirium research due to advances in technology. However, imaging delirious patients presents challenges leading to methodological limitations and restricted generalisability. The findings that atrophy and WMH burden predict delirium replicates findings from the original review, while advanced techniques have identified other substrates and mechanisms that warrant further investigation.
Collapse
Affiliation(s)
- Anita Nitchingham
- Department of Geriatric Medicine, Prince of Wales Hospital, Sydney, Australia.,Prince of Wales Clinical School, University of New South Wales, Sydney, Australia
| | - Varun Kumar
- Department of Psychiatry, Blacktown Hospital, Sydney, Australia
| | - Susan Shenkin
- Department of Geriatric Medicine, The University of Edinburgh, Edinburgh, UK
| | - Karen J Ferguson
- Department of Geriatric Medicine, The University of Edinburgh, Edinburgh, UK
| | - Gideon A Caplan
- Department of Geriatric Medicine, Prince of Wales Hospital, Sydney, Australia.,Prince of Wales Clinical School, University of New South Wales, Sydney, Australia
| |
Collapse
|
5
|
Aboulenein-Djamshidian F, Krššák M, Serbecic N, Rauschka H, Beutelspacher S, Kukurová IJ, Valkovič L, Khan A, Prayer D, Kristoferitsch W. CROP - The Clinico-Radiologico-Ophthalmological Paradox in Multiple Sclerosis: Are Patterns of Retinal and MRI Changes Heterogeneous and Thus Not Predictable? PLoS One 2015; 10:e0142272. [PMID: 26565967 PMCID: PMC4643899 DOI: 10.1371/journal.pone.0142272] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/26/2015] [Accepted: 10/20/2015] [Indexed: 12/28/2022] Open
Abstract
BACKGROUND To date, no direct scientific evidence has been found linking tissue changes in multiple sclerosis (MS) patients, such as demyelination, axonal destruction or gliosis, with either steady progression and/or stepwise accumulation of focal CNS lesions. Tissue changes such as reduction of the retinal nerve fiber layer (RNFL) and the total macular volume (TMV), or brain- and spinal cord atrophy indicates an irreversible stage of tissue destruction. Whether these changes are found in all MS patients, and if there is a correlation with clinical disease state, remains controversial. The objective of our study was to determine, whether there was any correlation between the RNFL or TMV of patients with MS, and: (1) the lesion load along the visual pathways, (2) the ratios and absolute concentrations of metabolites in the normal-appearing white matter (NAWM), (3) standard brain atrophy indices, (4) disease activity or (5) disease duration. METHODS 28 MS patients (RRMS, n = 23; secondary progressive MS (SPMS), n = 5) with moderately-high disease activity or long disease course were included in the study. We utilised: (1) magnetic resonance imaging (MRI) and (2) -spectroscopy (MRS), both operating at 3 Tesla, and (3) high-resolution spectral domain-OCT with locked reference images and eye tracking mode) to undertake the study. RESULTS There was no consistency in the pattern of CNS metabolites, brain atrophy indices and the RNFL/TMV between individuals, which ranged from normal to markedly-reduced levels. Furthermore, there was no strict correlation between CNS metabolites, lesions along the visual pathways, atrophy indices, RNFL, TMV, disease duration or disability. CONCLUSIONS Based on the findings of this study, we recommend that the concept of 'clinico-radiologico paradox' in multiple sclerosis be extended to CROP-'clinico-radiologico-ophthalmological paradox'. Furthermore, OCT data of MS patients should be interpreted with caution.
Collapse
Affiliation(s)
- Fahmy Aboulenein-Djamshidian
- Department of Neurology, SMZ-Ost Donauspital, A-1220 Langobardenstrasse 122, Vienna, Austria
- Karl Landsteiner Institute for Neuroimmunological and Neurodegenerative Disorders, A-1220 Langobardenstrasse 122, Vienna, Austria
- * E-mail:
| | - Martin Krššák
- High Field MR Centre, Department of Biomedical Imaging and Image Guided Therapy, Medical University of Vienna, A-1090 Währingergürtel 18-20, Vienna, Austria
- Division of Endocrinology and Metabolism, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria
| | - Nermin Serbecic
- Department of Ophthalmology, Medical University of Vienna, A-1090 Währingergürtel 18-20, Vienna, Austria
- Department of Ophthalmology, Medical Faculty Mannheim, University of Heidelberg, Theodor-Kutzer-Ufer 1-3, 68167 Mannheim, Germany
| | - Helmut Rauschka
- Department of Neurology, SMZ-Ost Donauspital, A-1220 Langobardenstrasse 122, Vienna, Austria
- Karl Landsteiner Institute for Neuroimmunological and Neurodegenerative Disorders, A-1220 Langobardenstrasse 122, Vienna, Austria
| | - Sven Beutelspacher
- Department of Ophthalmology, Medical Faculty Mannheim, University of Heidelberg, Theodor-Kutzer-Ufer 1-3, 68167 Mannheim, Germany
| | - Ivica Just Kukurová
- High Field MR Centre, Department of Biomedical Imaging and Image Guided Therapy, Medical University of Vienna, A-1090 Währingergürtel 18-20, Vienna, Austria
| | - Ladislav Valkovič
- High Field MR Centre, Department of Biomedical Imaging and Image Guided Therapy, Medical University of Vienna, A-1090 Währingergürtel 18-20, Vienna, Austria
| | - Adnan Khan
- Nuffield Department of Surgical Sciences, Division of Medical Sciences, University of Oxford, Oxford, United Kingdom
| | - Daniela Prayer
- Division of Neuroradiology and Musculo-Skeletal Radiology, Department of Biomedical Imaging and Image Guided Therapy, Medical University of Vienna, A-1090 Währinger Gürtel 18-20, Vienna, Austria
| | - Wolfgang Kristoferitsch
- Karl Landsteiner Institute for Neuroimmunological and Neurodegenerative Disorders, A-1220 Langobardenstrasse 122, Vienna, Austria
| |
Collapse
|
6
|
de la Espriella Guerrero R, de la Hoz Bradford AM, Zárate AUH, Lee PR, Menéndez MC, Rentería AMC, Hernández DC, Cardeño C, Barré MC, Kunzel GH, Gómez-Restrepo C. [Clinical Practice Guide for Early Detection, Diagnosis and Treatment of the Acute Intoxication Phase in Patients with Alcohol Abuse or Dependence: Part II: Evaluation and Management of Patients with Acute Alcohol Intoxication]. REVISTA COLOMBIANA DE PSIQUIATRIA 2012; 41:805-25. [PMID: 26572267 DOI: 10.1016/s0034-7450(14)60048-2] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/25/2012] [Accepted: 11/06/2012] [Indexed: 11/16/2022]
Abstract
INTRODUCTION Worldwide, alcohol is the second most-used psychotropic substance and the third risk factor for early death and disability. Its noxious use is a world public health problem given its personal, labor, family, economic and social impact. The identification of acute alcohol intoxication is extremely important, as well as the alcohol withdrawal syndrome and its complications, such as delirium tremens and Wernicke's encephalopathy in order to grant a timely treatment for those patients. This article introduces the evidence found so as to face and treat these clinic manifestations. METHODOLOGY Systematic revision of the evidence available together with an evaluation of pertinent guidelines found in literature so as to decide whether to adopt or adapt the existing recommendation for each question or to develop de novo recommendations. For de novo recommendations as well as those adapted, it was carried out an evidence synthesis, together with evidence tables and formulation of recommendations based on the evidence. RESULTS Evidence was found and recommendations were made for the diagnosis and treatment of acute alcohol intoxication, withdrawal syndrome, delirium tremens and Wernicke's encephalopathy.
Collapse
Affiliation(s)
- Ricardo de la Espriella Guerrero
- Médico psiquiatra, terapeuta sistémico, magíster Epidemiología Clínica, Pontificia Universidad Javeriana, director, Bogotá, Colombia.
| | - Ana María de la Hoz Bradford
- Médica cirujana, magíster en Epidemiología Clínica, Pontificia Universidad Javeriana, coordinadora GAI, Bogotá, Colombia
| | - Alina Uribe-Holguín Zárate
- Médica cirujana, residente de Psiquiatría, Pontificia Universidad Javeriana, asistente de investigación, Bogotá, Colombia
| | - Patricia Rodríguez Lee
- Médica cirujana, residente de Psiquiatría, Pontificia Universidad Javeriana, asistente de investigación, Bogotá, Colombia
| | - Miguel Cote Menéndez
- Médico psiquiatra, fellow en abuso de sustancias, Magíster en psicología y terapia sistémica, psiquiatra de CAD Fundar Bogotá, profesor de psiquiatría de la Facultad de Medicina de la Universidad Nacional de Colombia, experto temático, Bogotá, Colombia
| | - Ana María Cano Rentería
- Médica psiquiatra, miembro activo del subcomité de adicciones de la ACP, coordinadora del área científica de la ESE Hospital Mental de Filandia, Quindío, docente de clínica psiquiátrica, programa de Medicina de la Facultad de Ciencias de la Salud, Universidad del Quindío, entrenadora del Programa Treatnet II Colombia de ONU-DC. Asociación Colombiana de Psiquiatría, experta temática, Filandia, Quindío, Colombia
| | - Delia Cristina Hernández
- Médico psiquiatra, Universidad del Valle; máster en Conductas Adictivas, Universidad de Valencia; docente de Farmacodependencia, Universidad Libre; Asociación Colombiana de Psiquiatría; directora general de Fundar Colombia (Cali). Asociación Colombiana de Psiquiatría; Coordinadora del subcomité de adicciones de la ACP. Experta temática. Cali, Colombia
| | - Carlos Cardeño
- Médico Psiquiatra, psiquiatría de enlace. Magíster en Farmacología. Coordinador de Psiquiatría del Hospital Universitario Fundación Hospitalaria San Vicente de Paúl; Docente. Universidad de Antioquia. Experto temático, Bogotá, Colombia
| | - Michelle Cortés Barré
- Médica y cirujana, magíster en Educación, candidata a Maestría en Epidemiología Clínica. Pontificia Universidad Javeriana. Asistente de investigación. Bogotá, Colombia
| | - Gabriel Hernández Kunzel
- Médico psiquiatra, Hospital Militar Central y Clínica del Country; docente de Farmacodependencia de la Universidad Militar, Pontificia Universidad Javeriana y Universidad Sanitas. Miembro del Comité de Adicciones de la Asociación Colombiana de Psiquiatría. Asociación Colombiana de Psiquiatría. Experto temático, Bogotá, Colombia
| | - Carlos Gómez-Restrepo
- Médico psiquiatra, MSc Epidemiología Clínica, Psiquiatra de Enlace, Psicoanalista, profesor titular Departamento de Psiquiatría y Salud Mental, director Departamento de Psiquiatría y Salud Mental, director Departamento de Epidemiología Clínica y Bioestadística, Pontificia Universidad Javeriana, Director GAI Depresión, codirector CINETS, Bogotá, Colombia
| |
Collapse
|
7
|
Frydrychowski AF, Szarmach A, Czaplewski B, Winklewski PJ. Subarachnoid space: new tricks by an old dog. PLoS One 2012; 7:e37529. [PMID: 22701518 PMCID: PMC3365109 DOI: 10.1371/journal.pone.0037529] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/15/2012] [Accepted: 04/25/2012] [Indexed: 11/18/2022] Open
Abstract
PURPOSE The purpose of the study was to: (1) evaluate the subarachnoid space (SAS) width and pial artery pulsation in both hemispheres, and (2) directly compare magnetic resonance imaging (MRI) to near-infrared transillumination/backscattering sounding (NIR-T/BSS) measurements of SAS width changes in healthy volunteers. METHODS The study was performed on three separate groups of volunteers, consisting in total of 62 subjects (33 women and 29 men) aged from 16 to 39 years. SAS width was assessed by MRI and NIR-T/BSS, and pial artery pulsation by NIR-T/BSS. RESULTS In NIR-T/BSS, the right frontal SAS was 9.1% wider than the left (p<0.01). The SAS was wider in men (p<0.01), while the pial artery pulsation was higher in women (p<0.01). Correlation and regression analysis of SAS width changes between the back- and abdominal-lying positions measured with MRI and NIRT-B/SS demonstrated high interdependence between both methods (r = 0.81, p<0.001). CONCLUSIONS NIR-T/BSS and MRI were comparable and gave equivalent modalities for the SAS width change measurements. The SAS width and pial artery pulsation results obtained with NIR-T/BSS are consistent with the MRI data in the literature related to sexual dimorphism and morphological asymmetries between the hemispheres. NIR-T/BSS is a potentially cheap and easy-to-use method for early screening in patients with brain tumours, increased intracranial pressures and other abnormalities. Further studies in patients with intracranial pathologies are warranted.
Collapse
Affiliation(s)
| | | | - Bartosz Czaplewski
- Department of Teleinformation Networks, Gdansk University of Technology, Gdansk, Poland
| | - Pawel J. Winklewski
- Institute of Human Physiology, Medical University of Gdansk, Gdansk, Poland
- * E-mail:
| |
Collapse
|
8
|
Bühler M, Mann K. Alcohol and the human brain: a systematic review of different neuroimaging methods. Alcohol Clin Exp Res 2011; 35:1771-93. [PMID: 21777260 DOI: 10.1111/j.1530-0277.2011.01540.x] [Citation(s) in RCA: 220] [Impact Index Per Article: 15.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/18/2023]
Abstract
BACKGROUND Imaging techniques have been in widespread use in the scientific community for more than 3 decades. They facilitate noninvasive, in vivo studies of the human brain in both healthy and diseased persons. These brain-imaging techniques have contributed significantly to our understanding of the effects of alcohol abuse and dependence on structural and functional changes in the human brain. A systematic review summarizing these contributions has not previously been conducted, and this is the goal of the current paper. METHODS The databases PubMed, PsycINFO, and PSYNDEX were searched using central key words. Fulfilling the inclusion criteria were 140 functional and structural imaging studies, together comprising data from more than 7,000 patients and controls. The structural imaging techniques we considered were cranial computerized tomography and various magnetic resonance imaging-based techniques, including voxel-based morphometry, deformation-based morphometry, diffusion tensor magnetic resonance imaging, and diffusion-weighted magnetic resonance imaging. The functional methods considered were magnetic resonance spectroscopy, positron emission tomography, single photon emission computed tomography, and functional magnetic resonance imaging. RESULTS Results from studies using structural imaging techniques have revealed that chronic alcohol use is accompanied by volume reductions of gray and white matter, as well as microstructural disruption of various white matter tracts. These changes are partially reversible following abstinence. Results from functional imaging methods have revealed metabolic changes in the brain, lower glucose metabolism, and disruptions of the balance of neurotransmitter systems. Additionally, functional imaging methods have revealed increased brain activity in the mesocorticolimbic system in response to alcohol-themed pictures relative to nondrug-associated stimuli, which might be of predictive value with regard to relapse. CONCLUSIONS There has been tremendous progress in the development of imaging technologies. Use of these technologies has clearly demonstrated the structural and functional brain abnormalities that can occur with chronic alcohol use. The study of the alcoholic brain provides an heuristic model which furthers our understanding of neurodegenerative changes in general, as well as their partial reversibility with sustained abstinence. Additionally, functional imaging is poised to become an important tool for generating predictions about individual brain functioning, which can then be used as a basis for personalized medicine.
Collapse
Affiliation(s)
- Mira Bühler
- Department of Addictive Behavior and Addiction Medicine, Central Institute of Mental Health, University of Heidelberg, Mannheim, Germany
| | | |
Collapse
|
9
|
Soiza RL, Sharma V, Ferguson K, Shenkin SD, Seymour DG, Maclullich AMJ. Neuroimaging studies of delirium: a systematic review. J Psychosom Res 2008; 65:239-48. [PMID: 18707946 DOI: 10.1016/j.jpsychores.2008.05.021] [Citation(s) in RCA: 53] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/20/2008] [Revised: 05/03/2008] [Accepted: 05/15/2008] [Indexed: 12/20/2022]
Abstract
OBJECTIVE Neuroimaging offers clear potential in developing a better understanding of the pathophysiology of delirium. We performed a systematic review of structural and functional neuroimaging findings in delirium. The aims were to categorize and summarize the existing literature, and to determine whether this literature provides conclusive information on structural or functional brain predictors, correlates, or consequences of delirium. METHODS Studies were identified by comprehensive textword and MeSH-based electronic searches of MEDLINE, EMBASE, and Evidence-Based Medicine reviews, combining multiple terms for neuroimaging, brain structure, and delirium. RESULTS Twelve studies met the inclusion criteria. There were a total of 194 patients with delirium and 570 controls. Patient age, population, comorbidities, and identified precipitating factors were heterogeneous. Of the 10 structural studies, 3 studies used computed tomography (CT), 3 studies used magnetic resonance imaging (MRI), and 4 studies used a mixture of CT and MRI. One functional study used xenon CT, and the other used single photon emission computed tomography. There was a wide range of measurement techniques and timing of scans. Some studies found associations between delirium and cortical atrophy, and between ventricular enlargement and white matter lesion burden, but many studies did not control for potential confounders. Only two small studies of cerebral blood flow were identified, with both suggesting that there may be reduced regional cerebral blood flow, but the data were limited and somewhat inconsistent. CONCLUSIONS The small sample sizes and other limitations of the studies identified in this review preclude drawing any clear conclusions regarding neuroimaging findings in delirium, but these studies suggest multiple avenues for future research.
Collapse
Affiliation(s)
- Roy L Soiza
- Department of Medicine and Therapeutics, University of Aberdeen, Aberdeen, Scotland, UK.
| | | | | | | | | | | |
Collapse
|